Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pickleball program boosts health and wellness for cancer survivors, study finds

2.

O. A. J. Simpson passes away from cancer.

3.

Guidelines for cervical cancer screening and the risk of preterm birth in young women.

4.

In cancer patients taking immune checkpoint inhibitors, systematic vitamin D supplementation improves outcomes.

5.

What Comes After Cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot